EDESA BIOTECH, INC. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EDESA BIOTECH, INC. stock issued during period, value, conversion of units for the quarter ending 2021-03-31 was $1.38M.
- EDESA BIOTECH, INC. stock issued during period, value, conversion of units for the quarter ending 2020-12-31 was $1.12M.
- EDESA BIOTECH, INC. stock issued during period, value, conversion of units for fiscal 2020 was $0.00.
- EDESA BIOTECH, INC. stock issued during period, value, conversion of units for fiscal 2018 was $0.00.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2021-03-31 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-14 | |
| 2020-12-31 | $1.12M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $0.00 10-K · filed 2020-12-07 | |
| 2018-12-31 | $0.00 10-KT · filed 2019-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |